Cost impact of in-patient specialist palliative care: A retrospective economic study of administrative end-of-life hospital costs across 7 years in Switzerland.

IF 2.7 Q2 HEALTH CARE SCIENCES & SERVICES
Palliative Care and Social Practice Pub Date : 2026-06-10 eCollection Date: 2026-01-01 DOI:10.1177/26323524261452273
Monika Hagemann, Matthias Schwenkglenks, Odile Stalder, Steffen Eychmüller, Maud Maessen
{"title":"Cost impact of in-patient specialist palliative care: A retrospective economic study of administrative end-of-life hospital costs across 7 years in Switzerland.","authors":"Monika Hagemann, Matthias Schwenkglenks, Odile Stalder, Steffen Eychmüller, Maud Maessen","doi":"10.1177/26323524261452273","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While healthcare costs continue to grow, an aging population along with rising chronic diseases are increasing demand for high-quality end-of-life care.</p><p><strong>Objective: </strong>Our objectives include calculating hospital cost sub-categories, such as laboratory, medication, nursing, physician, and social counseling, and evaluating the economic impact of specialist palliative care (sPC) on overall hospital costs per stay and per day of severely ill and dying patients who died at a Swiss university hospital between 2016 and 2022.</p><p><strong>Design: </strong>Retrospective, observational cohort study with a control group.</p><p><strong>Methods: </strong>We used administrative cost data from the final hospitalization of patients who died at a university hospital in Switzerland. We compared hospital costs of patients receiving care, including sPC, with those of individuals receiving usual care (UC). We defined timely sPC referral as initiating within 3 days of admission. We used a generalized linear model-assuming gamma-distributed errors and with a logarithmic link function-adjusted by inverse probability weighting to adjust for patient characteristics differences.</p><p><strong>Results: </strong>Adjusted overall hospital costs per stay were higher for sPC (Swiss francs (CHF) 31,350 (95% confidence interval (CI) 28,590-34,854)) compared with UC patients (CHF 20,351 (95% CI 18,454-22,596)); mean ratio of 1.54 ((95% CI 1.34-1.77), <i>p</i> < 0.001). In contrast, adjusted overall daily costs were lower for sPC patients (CHF 400); mean ratio 0.87 ((95% CI 0.79-0.97), <i>p</i> = 0.005), mainly due to reduced diagnostic and medication costs. However, longer hospital stays (sPC 11 days vs UC 5 days) offset daily cost reductions. UC patients had nearly double the total costs of timely sPC referral patients (cost ratio 0.52, CI 0.46-0.58).</p><p><strong>Conclusion: </strong>To capture intended and unintended effects and avoid oversimplified cost debates, hospital cost analyses of sPC should examine detailed cost sub-categories rather than only total costs. Cost optimization could be reached by timely transfer of patients with sPC needs. Future studies should investigate barriers to transitioning patients across care settings to improve both quality and cost-effectiveness.</p>","PeriodicalId":36693,"journal":{"name":"Palliative Care and Social Practice","volume":"20 ","pages":"26323524261452273"},"PeriodicalIF":2.7000,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13260971/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Palliative Care and Social Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26323524261452273","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: While healthcare costs continue to grow, an aging population along with rising chronic diseases are increasing demand for high-quality end-of-life care.

Objective: Our objectives include calculating hospital cost sub-categories, such as laboratory, medication, nursing, physician, and social counseling, and evaluating the economic impact of specialist palliative care (sPC) on overall hospital costs per stay and per day of severely ill and dying patients who died at a Swiss university hospital between 2016 and 2022.

Design: Retrospective, observational cohort study with a control group.

Methods: We used administrative cost data from the final hospitalization of patients who died at a university hospital in Switzerland. We compared hospital costs of patients receiving care, including sPC, with those of individuals receiving usual care (UC). We defined timely sPC referral as initiating within 3 days of admission. We used a generalized linear model-assuming gamma-distributed errors and with a logarithmic link function-adjusted by inverse probability weighting to adjust for patient characteristics differences.

Results: Adjusted overall hospital costs per stay were higher for sPC (Swiss francs (CHF) 31,350 (95% confidence interval (CI) 28,590-34,854)) compared with UC patients (CHF 20,351 (95% CI 18,454-22,596)); mean ratio of 1.54 ((95% CI 1.34-1.77), p < 0.001). In contrast, adjusted overall daily costs were lower for sPC patients (CHF 400); mean ratio 0.87 ((95% CI 0.79-0.97), p = 0.005), mainly due to reduced diagnostic and medication costs. However, longer hospital stays (sPC 11 days vs UC 5 days) offset daily cost reductions. UC patients had nearly double the total costs of timely sPC referral patients (cost ratio 0.52, CI 0.46-0.58).

Conclusion: To capture intended and unintended effects and avoid oversimplified cost debates, hospital cost analyses of sPC should examine detailed cost sub-categories rather than only total costs. Cost optimization could be reached by timely transfer of patients with sPC needs. Future studies should investigate barriers to transitioning patients across care settings to improve both quality and cost-effectiveness.

住院专科姑息治疗的成本影响:瑞士7年来行政临终医院成本的回顾性经济研究。
背景:随着医疗保健费用的持续增长,人口老龄化以及慢性病的增加对高质量临终关怀的需求也在增加。目的:我们的目标包括计算医院成本子类别,如实验室、药物、护理、医生和社会咨询,并评估专家姑息治疗(sPC)对2016年至2022年期间在瑞士大学医院死亡的重症和垂死患者每次住院和每天总医院成本的经济影响。设计:回顾性、观察性队列研究,并设对照组。方法:我们使用瑞士某大学医院死亡患者最后住院的行政费用数据。我们比较了接受护理(包括sPC)的患者与接受常规护理(UC)的患者的住院费用。我们将及时的sPC转诊定义为在入院3天内开始。我们使用广义线性模型-假设伽马分布误差和对数链接函数-通过逆概率加权调整以调整患者特征差异。结果:与UC患者(20,351瑞士法郎(95%置信区间18,454-22,596))相比,sPC患者每次住院的调整后总住院费用更高(瑞士法郎31,350(95%置信区间(CI) 28,590-34,854));平均比值为1.54 ((95% CI 1.34-1.77), p = 0.005),主要原因是诊断和用药费用降低。然而,较长的住院时间(sPC 11天vs UC 5天)抵消了日常成本的降低。UC患者的总费用几乎是及时转诊sPC患者的两倍(成本比0.52,CI 0.46-0.58)。结论:为了捕捉预期的和非预期的影响,避免过度简化的成本争论,sPC的医院成本分析应该检查详细的成本子类别,而不仅仅是总成本。通过及时转移有sPC需求的患者,可以实现成本优化。未来的研究应该调查患者在不同护理环境中转移的障碍,以提高质量和成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Palliative Care and Social Practice
Palliative Care and Social Practice Nursing-Advanced and Specialized Nursing
CiteScore
2.90
自引率
0.00%
发文量
37
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书